← Leaderboards
Robert G. Hawley
American National Red Cross
$4,907,225
Attributed
$5,115,600
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $402.8K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,115,600 · 3
By mechanism
R01$4,698,850 · 2
R21$416,750 · 1
Top collaborators
- Weiqun Peng2 shared
Most similar at American National Red Cross
Same institution · by research overlap
- David William Scott$13,836,753
- Evgueni L. Saenko$2,390,774
- Dorothea H Scandella$271,250
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsTissue /Cell CultureTransfection /Expression VectorGenetic Promoter ElementGene TherapyChromatinLaboratory MouseRegulationMolecularRna SplicingMesodermHuman TissueHuman Immunodeficiency Virus 1LentivirusInterferon BetaMicroarray TechnologyGreen Fluorescent ProteinsGenetic TransductionGene ExpressionFlow CytometryCell DifferentiationCell LineHomeobox GenesDisease /Disorder Model
Grant awards (15)
Characterization of Regulated Intron Retention in T Cell Activation$190,625
R21 · FY2015 · AI
Characterization of Regulated Intron Retention in T Cell Activation$226,125
R21 · FY2014 · AI
Molecular Chimerism Therapy for Hemophilia A$371,408
R01 · FY2009 · HL · contact PI
Molecular Chimerism Therapy for Hemophilia A$371,408
R01 · FY2008 · HL · contact PI
Molecular Chimerism Therapy for Hemophilia A$371,408
R01 · FY2007 · HL · contact PI
Molecular Chimerism Therapy for Hemophilia A$382,500
R01 · FY2006 · HL · contact PI
Embryoid Body-derived Hematopoietic Stem Cell Lines$402,849
R01 · FY2005 · HL
Lentiviral Vectors for Position-Independent Expression$435,770
R01 · FY2004 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines$397,457
R01 · FY2004 · HL
Lentiviral Vectors for Position-Independent Expression$346,950
R01 · FY2003 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines$308,400
R01 · FY2003 · HL
Lentiviral Vectors for Position-Independent Expression$346,950
R01 · FY2002 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines$308,400
R01 · FY2002 · HL
Lentiviral Vectors for Position-Independent Expression$346,950
R01 · FY2001 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines$308,400
R01 · FY2001 · HL